Sat 28 Nov 2009 | 8:23 EST

You are here: Home > Business & Finance > Stocks > Officers and Directors

Do More With Reuters

Partner Services

Affiliate Network

Professional Products

Support (Customer Zone)

Financial Products

About Thomson Reuters

Officers and Directors For Facet Biotech Corporation

Facet Biotech Corporation (FACT.O) (Consolidated Issue listed on NASDAQ Global Market)

sector: Healthcare . industry: Pharmaceuticals - Generic & Specialty · View FACT on other exchanges

As of 27 Nov 2009

16.48USD

Price Change

-0.29

Percent Change

-1.73%

Analyst Recommendations

Independent Research | Broker Research

Name	Total Annual Compensation	Long-Term Incentive Plans	All Other	Fiscal Year Total
As Of 30 Dec 2008
Cross, Herbert	--	--	--	--
Goodwin, Bradford	--	--	--	--
Guggenhime, Andrew	641,804	--	324,097	1,095,490
Hasnain, Faheem	215,240	--	25,787	241,027
Hora, Maninder	488,451	--	335,546	830,514
Huh, Hoyoung	--	--	--	--
Llana, Ted	--	--	--	--
Lyons, Gary	--	--	--	--
McCamish, Mark	648,151	--	185,191	950,732
Parkinson, David	--	--	--	--
Sarena, Francis	--	--	--	--
Von Emster, Kurt	--	--	--	--

Find out more about FACT.O

Insider Trading

Reuters.com: Help and Contact Us | Advertise With Us | Mobile | Newsletters | RSS | Labs | Journalism Handbook | Archive | Site Index | Video Index

Thomson Reuters Corporate: Copyright | Disclaimer | Privacy | Professional Products | Professional Products Support | About Thomson Reuters | Careers

International Editions: Africa | Arabic | Argentina | Brazil | Canada | China | France | Germany | India | Italy | Japan | Latin America | Mexico | Russia | Spain | United Kingdom | United States

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.